In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB
about
Insights into the pharmacokinetic properties of antitubercular drugs.Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection modelComputational pharmacology of rifampin in mice: an application to dose optimization with conflicting objectives in tuberculosis treatment.Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives.PK/PD models in antibacterial development.A Diffusion-Based and Dynamic 3D-Printed Device That Enables Parallel in Vitro Pharmacokinetic Profiling of MoleculesCurrent status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis.Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents.Translational PK/PD of anti-infective therapeutics.The Hollow Fiber System Model in the Nonclinical Evaluation of Antituberculosis Drug Regimens.Determination of compound kill kinetics against Mycobacterium tuberculosis.Hit Generation in TB Drug Discovery: From Genome to Granuloma.Moxifloxacin target site concentrations in patients with pulmonary TB utilizing microdialysis: a clinical pharmacokinetic study.Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensive Drug-resistant Pseudomonas aeruginosa.
P2860
Q30251497-C2E5FAE1-84E6-4FB4-9952-0DBF4CE061C1Q35864589-E7D5AEAD-718B-4131-BDD1-0077A07960C4Q36082913-7891A12E-01B8-4D37-B28F-4C7ACB016D24Q37259653-A5B8DA04-9EE3-4B74-AFDA-24A3673323A3Q37325658-C05F0533-0346-43B8-BB8A-08E2FF104105Q37630801-EA6E87CB-861D-44AC-898E-525270DA447FQ38763608-CF123F5C-8310-4680-9990-C5C359EF4A6FQ38920104-D51EBDD9-0382-4923-B074-585D4B406BBFQ39039505-E115C0BD-CEBD-4467-8760-4AE71F882DA4Q39133476-71F02689-9BE4-46E6-B18B-9208F2EC8478Q41425744-C629CC4E-FD37-4E9E-B6EF-74D70DF5E6CBQ47702665-BF92B697-2331-4432-961E-B2820998C73BQ49548970-6ECC3262-27AF-4F74-BF63-71AED33156AFQ52597958-C0AA230B-5367-4E4B-B422-28F7210BA2C8
P2860
In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
In vitro pharmacokinetic/pharm ...... drug development: focus on TB
@en
In vitro pharmacokinetic/pharm ...... drug development: focus on TB
@nl
type
label
In vitro pharmacokinetic/pharm ...... drug development: focus on TB
@en
In vitro pharmacokinetic/pharm ...... drug development: focus on TB
@nl
prefLabel
In vitro pharmacokinetic/pharm ...... drug development: focus on TB
@en
In vitro pharmacokinetic/pharm ...... drug development: focus on TB
@nl
P2860
P356
P1476
In vitro pharmacokinetic/pharm ...... drug development: focus on TB
@en
P2093
Pavan K Vaddady
P2860
P304
P356
10.4155/FMC.10.224
P577
2010-08-01T00:00:00Z